Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01880580 · ClinicalTrials.gov registry record
Cone Beam CT for Breast Imaging
A clinical trial, sponsored by Koning Corporation.
- Completed
- Registry status
- 76
- Enrollment target
NCT01880580: Completed study, sponsored by Koning Corporation.
NCT01880580 is a clinical trial that has completed, run by Koning Corporation. The registered enrollment target is 76 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01880580 has completed, sponsored by Koning Corporation.
- COMPLETED
- Registry status
- 76 participants
- Enrollment target
Study Summary
The objective of this pilot study is to investigate Cone Beam Computed Tomography Imaging (CBCT), with the primary goal, the accumulation of a body of evidence to provide preliminary data for a future extensive clinical trials.
Primary Outcome
This study was to evaluate the radiation dose, breast coverage, and image quality of cone-beam breast CT compared with a conventional mammographic examination.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2006-07 |
| Est. Completion | 2012-06 |
What the finished NCT01880580 record still lists
NCT01880580 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 76 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01880580 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01880580 about?
NCT01880580 is a clinical study titled "Cone Beam CT for Breast Imaging". The objective of this pilot study is to investigate Cone Beam Computed Tomography Imaging (CBCT), with the primary goal, the accumulation of a body of evidence to provide preliminary data for a future extensive clinical trials.
What is the current status of trial NCT01880580?
This trial is currently completed. The enrollment target is 76 participants. The study started on 2006-07. Estimated completion is 2012-06.
Who is sponsoring clinical trial NCT01880580?
This trial is sponsored by Koning Corporation, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02615184 · 76 participants · Phase 2
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
- NCT02821741 · 76 participants · NA
Effects of External Ear Stimulation on Pain Perception and Mood
- NCT03019757 · 76 participants
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- NCT03353584 · 76 participants · NA
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia